SmithRx Stock

SmithRx is reinventing PBMs with modern technology, client alignment, and 100% transparency.

Sign up today and learn more about SmithRx Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About SmithRx Stock

SmithRx is a pharmacy benefits partner built on a modern technology platform that creates new levels of flexibility, efficiency, and customer satisfaction. It’s a new path forward that aligns incentives and harnesses data analytics to deliver an exceptional pharmacy benefit product. A San Francisco-based technology company, SmithRx was founded in 2016 to create a cost-competitive PBM that offers clients a proven pass-through model, a single technology platform, concierge-level service, and strong drug cost, rebate, and service level guarantees. The in-house team brings together experience from healthcare companies including Anthem, Collective Health, and Castlight Health, as well as a broader set of technology leaders including Facebook, LinkedIn, Glassdoor, and Docker. Front-line clinicians guide plan execution and member support. Named after a smith, a craftsman, or someone who is precise about their trade. SmithRx embodies these characteristics and brings precision to the pharmacy benefits industry by leveraging technology and data to forge the product of the future.

Funding History

March 2017$3.0M
January 2018$9.0M
July 2018$5.5M
March 2022$20.0M
January 2024$60.0M


Advisor, Angel

Ethan Fassett


Matt Bornstein

Founder & CEO

Jake Frenz

Technical Architect

David Lawrence


Sven Junkergard

Board Observer

Bob Kocher

VP of Revenue

Sam Slaughter

Board Member

Bryan Roberts


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: